| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-102 |
| PharmacoGx | KIN001-102 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DNTT | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-16 |
| mRNA | GIMAP6 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-15 |
| mRNA | BCL11B | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-14 |
| mRNA | MYB | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-13 |
| mRNA | MDFI | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | CD3G | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-12 |
| mRNA | LDLRAD4 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | NDST3 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-12 |
| mRNA | ABHD17B | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-12 |
| mRNA | TRAT1 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-12 |
